InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: MontanaState83 post# 282588

Wednesday, 06/24/2020 8:40:35 AM

Wednesday, June 24, 2020 8:40:35 AM

Post# of 426389
MS83....

Do realize most of the time this TTE has been playing the roll of class clown on this board..Changing his identity monthly..And now you think he is the "Sage of Omaha."

None of us including "TTE", "The Bus", TasGreWaf (stands for "Tasty green Wafers")...Know how this trial is going to play out.

Settlement is an option..Right now the whole situation is very convoluted because the court at best has the Generics in a position where the temptation to shoe horn into the R-I indication is overwhelming..But from a legal standpoint it would be breaking the law..If they are caught (and right now nobody can put odds on that)...It could be very expensive.

In the meantime..Winning the MARINE indication..is back seat in the garbage wagon..The FDA label for Indications and Usage is the same for both The Marine Vascepa label and for Generic Lovaza..The exact word for word same..The fact V cures CVD does not come into play and if the generics try and promote this they will be indirectly inducing patent infringement..

The generics are dammed if they do..or dammed if they don't..Unless they can figure out a way to produce and sell Marine Gen Vascepa at a price lower than Teva can sell gen L then they are going to lose most of their market for Gen Vascepa..

So settlement might be the road to go..

JMO..":>) JL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News